Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Kindred Biosciences (NQ: KIN )

4.930 USD +0.480 (+10.79%)
Official Closing Price Updated: 7:58 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,292,300
Open 4.410
Bid (Size) 4.930 (3)
Ask (Size) 5.080 (7)
Prev. Close 4.450
Today's Range 4.330 - 4.970
52wk Range 3.110 - 11.93
Shares Outstanding 33,748,738
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Kindred Biosciences Initiates Pivotal Efficacy Study of Tirnovetmab (Interleukin-31) Monoclonal Antibody for Canine Atopic Dermatitis
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has initiated the pivotal efficacy study for tirnovetmab... 
From PR Newswire
Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFα Antibody for Canine Inflammatory Bowel Disease
Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced positive results from the pilot field effectiveness study of its... 
From PR Newswire

Performance

YTD
+10.79%
+10.79%
1 Month
+9.07%
+9.07%
3 Month
+21.43%
+21.43%
6 Month
+27.06%
+27.06%
1 Year
-48.96%
-48.96%

More News

Read More
Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal Antibody
From PR Newswire
Kindred Biosciences to Present at Guggenheim Animal Health Summit
From PR Newswire
Kindred Biosciences to Participate in Stifel Virtual Healthcare Conference and A.G.P. Virtual Healthcare Symposium
From PR Newswire
Kindred Biosciences Announces Third Quarter 2020 Financial Results
From PR Newswire
Elanco Announces Agreement with KindredBio to Bring First-of-its-Kind Canine Parvovirus Therapy to Market
From Business Wire News Releases
Kindred Biosciences to Announce Third Quarter 2020 Financial Results
From PR Newswire
Centaur Biopharmaceutical Services Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates
From PR Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
Tags ACST HOTH Market News
From Benzinga
Kindred Biosciences Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.